Literature DB >> 26306058

Psychological Characteristics in Patients during Treatment for Tobacco Dependence.

Akiko Matsuda1, Junichi Hasegawa2, Xinhui Wang2, Satoshi Tsuno2, Norimasa Miura2.   

Abstract

BACKGROUND: Few studies compare mood in tobacco cessation patients with mood in continuing smokers and then estimate the effects of a tobacco cessation program according to status of mood. We investigated whether mood in patients (n = 7) dependent on tobacco improved through the standard Japanese 12-week program for smoking cessation comparing smokers (n = 11) and nonsmokers (n = 16).
METHODS: A brief Japanese version of the short profile of mood states (POMS) was used in this study. The subscale includes 5 negative mood factors (tension-anxiety, depression, anger-hostility, fatigue and confusion-bewilderment) and positive mood factors (vigor-activity). We also examined expiratory CO concentration (ppm), percentage of COHb, urinary nicotine and its metabolite concentration, Brinkman index, and tobacco dependence score (TDS) for both smoking cessation group and smokers group.
RESULTS: All the short profiles for mood state points in nonsmokers were below 50. Two of TDS items in smoking cessation patients were significantly higher in percentage than those in smokers. Brinkman indices and expiratory CO concentration were significantly higher in smoking cessation patients than those in smokers. The rate of improvement in tension-anxiety points in smoking cessation patients was significantly higher than that in smokers.
CONCLUSION: Counseling according to the standard program in the treatment of tobacco dependence may be an effective procedure to improve mood status.

Entities:  

Keywords:  mood states; psychological characteristic; smoker; smoking cessation; tobacco dependence

Year:  2015        PMID: 26306058      PMCID: PMC4546960     

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  9 in total

1.  Smoking cessation and the course of major depression: a follow-up study.

Authors:  A H Glassman; L S Covey; F Stetner; S Rivelli
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

Review 2.  Monoamine oxidases and tobacco smoking.

Authors:  I Berlin; R M Anthenelli
Journal:  Int J Neuropsychopharmacol       Date:  2001-03       Impact factor: 5.176

Review 3.  Distress tolerance and early smoking lapse.

Authors:  Richard A Brown; C W Lejuez; Christopher W Kahler; David R Strong; Michael J Zvolensky
Journal:  Clin Psychol Rev       Date:  2005-09

4.  Development of a mental health action checklist for improving workplace environment as means of job stress prevention.

Authors:  Toru Yoshikawa; Norito Kawakami; Kazutaka Kogi; Akizumi Tsutsumi; Miyuki Shimazu; Makiko Nagami; Akihito Shimazu
Journal:  Sangyo Eiseigaku Zasshi       Date:  2007-07

Review 5.  A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups.

Authors:  Jamie Bryant; Billie Bonevski; Chris Paul; Patrick McElduff; John Attia
Journal:  Addiction       Date:  2011-07-22       Impact factor: 6.526

6.  A day at a time: predicting smoking lapse from daily urge.

Authors:  S Shiffman; J B Engberg; J A Paty; W G Perz; M Gnys; J D Kassel; M Hickcox
Journal:  J Abnorm Psychol       Date:  1997-02

7.  Maintenance of brain monoamine oxidase B inhibition in smokers after overnight cigarette abstinence.

Authors:  J S Fowler; G J Wang; N D Volkow; D Franceschi; J Logan; N Pappas; C Shea; R R MacGregor; V Garza
Journal:  Am J Psychiatry       Date:  2000-11       Impact factor: 18.112

Review 8.  Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities.

Authors:  J R Hughes; S T Higgins; W K Bickel
Journal:  Addiction       Date:  1994-11       Impact factor: 6.526

9.  Changes in prevalence of depression and anxiety following smoking cessation: results from an international cohort study (ATTEMPT).

Authors:  L Shahab; S Andrew; R West
Journal:  Psychol Med       Date:  2013-03-14       Impact factor: 7.723

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.